LONGEZYME
Food supplement declared in France, declaration No 2022-4-511, decision dated 12 April 2022
LONGEZYME is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- LONGEVIE s.a.
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Gélule
- Daily dose
- 1 à 2 gélules par jour
- Directions for use
- 1 à 2 gélules par jour
- Objectives stated by the manufacturer (these are not authorised claims)
- Digestion
Declaration 263210, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Other active ingredients
| Name | Per day |
|---|---|
| Alpha-galactosidase | not declared |
| Amylase | not declared |
| Bromélaïne | not declared |
| Cellulase | not declared |
| Glucoamylase | not declared |
| Hémicellulase | not declared |
| Lactase | not declared |
| Lipase | not declared |
| Papaïne | not declared |
| Pectinase | not declared |
| Phytase | not declared |
| Protéase | not declared |
Additives
E551, E464, E470b
Other ingredients
Amidon de manioc, maltodextrine
Has the product changed? Photograph the packaging.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.